Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

November 17, 2020
Review
Open Access

Astrocytic Calcium Dynamics Along the Pain Pathway

Frontiers in Cellular Neuroscience
Jeiwon Cho, Yeowool Huh
November 21, 2020
Open Access

An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases

Molecular Neurodegeneration
Jerome RobertCheryl Wellington
November 22, 2020

Chemical mutagenesis of a GPCR ligand: Detoxifying "inflammo-attraction" to direct therapeutic stem cell migration

Proceedings of the National Academy of Sciences of the United States of America
Jean-Pyo LeeEvan Y Snyder
November 19, 2020

Progressive supranuclear palsy: Neuropathology of patients with a short disease duration due to unexpected death

Neuropathology : Official Journal of the Japanese Society of Neuropathology
Lu ZhangAkiyoshi Kakita
November 22, 2020

Laquinimod Modulates Human Astrocyte Function and Dampens Astrocyte-Induced Neurotoxicity during Inflammation

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Emanuela ColomboCinthia Farina
November 17, 2020
Review
Open Access

Microglial Immunometabolism in Alzheimer's Disease

Frontiers in Cellular Neuroscience
Daniel C Shippy, Tyler K Ulland
November 17, 2020
Open Access

Gut microbiota modulates expression of genes involved in the astrocyte-neuron lactate shuttle in the hippocampus

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Michael B MargineanuPierre J Magistretti
November 12, 2020
Review

Roles of N-myc downstream-regulated gene 2 in the central nervous system: molecular basis and relevance to pathophysiology

Anatomical Science International
Mika Takarada-Iemata
November 21, 2020
Open Access

Increased C-X-C Motif Chemokine Ligand 12 Levels in Cerebrospinal Fluid as a Candidate Biomarker in Sporadic Amyotrophic Lateral Sclerosis

International Journal of Molecular Sciences
Pol Andrés-BenitoIsidro Ferrer
November 20, 2020
Review
Open Access

Locus Coeruleus Modulates Neuroinflammation in Parkinsonism and Dementia

International Journal of Molecular Sciences
Filippo Sean GiorgiFrancesco Fornai

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the microenvironment and neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modelled by induced pluripotent stem cell derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research here.

ALS

Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) share a considerable proportion of characteristics including the same neuropathological substrate of abnormally phosphorylated TAR DNA binding protein (TDP-43). Here are the latest discoveries pertaining to ALS, FTD and TDP-43.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Age-related Dementia

Age-related dementias present as cognitive decline that is not a part of normal aging. Age-related dementias include Alzheimer's disease, vascular dementia, and Lewy body dementia. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/astrocytes-neurodegeneration/727e14b1-f6e5-4e9b-b062-4a402668f43e